Fight the Fakes Infographic – Same Packaging, Same Shape and Same Color… But Fakes!
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
Related news and resources
Navigating the ECOWAS Joint Assessment Procedure
The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.
Read more
Key considerations on the scope, utility and processes around updating the WHO Essential Medicines List
The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.
Read moreRegistration of multiple manufacturing sites in one product license
In a joint position paper, EFPIA, IFPMA and Vaccines Europe urge all countries to adopt a ‘multiple-site-to-one-license’ approach for registrations, in line with WHO and other guidelines. This will result in a reduction of duplicate work for all stakeholders, help to build agility and speed in supply chain management and improve patient access to medicines and vaccines.
Read more